A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio
The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. We...
Saved in:
Published in | Cancer management and research Vol. 11; pp. 4719 - 4728 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.05.2019
Dove Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy.
We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test.
The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ
=7.267,
=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ
=5.414,
=0.020) and tended to die within one year (23.5% vs 10.9%, χ
=10.871,
=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827,
=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954,
=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952,
=0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925,
=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898,
=0.015).
The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy. |
---|---|
AbstractList | Ningbo Fan,1,* Dongni Chen,1,* Jiabo Zheng,2 Zhesheng Wen,1 Peng Lin11Department of Thoracic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China; 2Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, People's Republic of China*These authors contributed equally to this workPurpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy.Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test.Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ2=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ2=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, χ2=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, P=0.015).Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy.Keywords: esophageal squamous cell carcinoma, prognostic indicator, fibrinogen, lymphocyte The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test. The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ =7.267, =0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ =5.414, =0.020) and tended to die within one year (23.5% vs 10.9%, χ =10.871, =0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, =0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, =0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, =0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, =0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, =0.015). The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy. Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan–Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ 2 =7.267, P =0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ 2 =5.414, P =0.020) and tended to die within one year (23.5% vs 10.9%, χ 2 =10.871, P =0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P =0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P =0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073–1.952, P =0.015), DFS (HR: 1.445, 95%CI: 1.084–1.925, P =0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157–3.898, P =0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy. Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low ([less than or equal to]3.03) group, the FLR-high (>3.03) group included older patients ([chi square]=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, [chi square]=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, [chi square]=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy. Keywords: esophageal squamous cell carcinoma, prognostic indicator, fibrinogen, lymphocyte Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ2=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ2=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, χ2=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy.Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ2=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ2=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, χ2=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy. |
Audience | Academic |
Author | Zheng, Jiabo Lin, Peng Fan, Ningbo Chen, Dongni Wen, Zhesheng |
Author_xml | – sequence: 1 givenname: Ningbo surname: Fan fullname: Fan, Ningbo – sequence: 2 givenname: Dongni surname: Chen fullname: Chen, Dongni – sequence: 3 givenname: Jiabo orcidid: 0000-0001-7834-5103 surname: Zheng fullname: Zheng, Jiabo – sequence: 4 givenname: Zhesheng orcidid: 0000-0002-0065-7542 surname: Wen fullname: Wen, Zhesheng – sequence: 5 givenname: Peng orcidid: 0000-0003-3760-5575 surname: Lin fullname: Lin, Peng |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31213896$$D View this record in MEDLINE/PubMed |
BookMark | eNptkkuP0zAUhSM0iJkp7FgjS2xYkOJXkoYFUlXxGGkQEo-15TjXrUdJnLHdov4m_iQ3tDOaolEWfn3n-PrmXGZngx8gy14yOudMVu9WX5ff5z84lbVYPMkuGKvqnAnOzx7Mz7PLGG8oLWsm5LPsXDDOxKIuL7I_SzL4HXRkDOBHCDq5HZCx07HXxA2tMzr5QJKfAFwlHP168BEisXgwogCGFMlvlzYEoh83eg26I_F2q3u_jcRA1xGjg3GDR09tEwQS9OTc3QtM8v3-PbGuCYitYciTz7t9P2682ScgU13-efbU6i7Ci-M4y359-vhz9SW__vb5arW8zk3BqpTb2hrGBRNtUzKo2qIG0EbLsmgp062hRoLQhWwlL3FiLa8kaEHrAlopKyZm2dXBt_X6Ro3B9TrslddO_dvwYa10SM50oCposJWW0oqiYW0bA2XL8T5tedPgPbPsw8Fr3DY9tAZ7FXR3Ynp6MriNWvudKgtRVrRGgzdHg-BvtxCT6l2ceqoHwPYqzqWQC1nVEtHXB3StsTQ3WI-OZsLVsmS0QKqskJo_QuHXQu8MZss63D8RvHr4hPva70KEAD8AJvgYA1hlXJp-2PQi1ylG1ZRUNSVVHZOKorf_ie58H8X_At6m73Q |
CitedBy_id | crossref_primary_10_3390_jpm11111228 crossref_primary_10_3389_fonc_2022_1003845 crossref_primary_10_11569_wcjd_v27_i18_1133 crossref_primary_10_1245_s10434_021_10848_8 crossref_primary_10_2147_IJGM_S407833 crossref_primary_10_3389_fonc_2020_00797 crossref_primary_10_3389_fonc_2022_992929 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 Dove Medical Press Limited 2019 Fan et al. 2019 Fan et al. |
Copyright_xml | – notice: COPYRIGHT 2019 Dove Medical Press Limited – notice: 2019 Fan et al. 2019 Fan et al. |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.2147/CMAR.S204938 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Fan et al |
EISSN | 1179-1322 |
EndPage | 4728 |
ExternalDocumentID | oai_doaj_org_article_7eb121f007054d9fbce6d2eeaaf2bb4e PMC6536709 A610584767 31213896 10_2147_CMAR_S204938 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- 0YH 29B 2WC 53G 5VS 7X7 8FI 8FJ 8G5 AAYXX ABUWG ACGFO ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI C1A CCPQU CITATION DIK DWQXO E3Z EBD F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HMCUK HYE IAO IHR IPNFZ ITC KQ8 M2O M48 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RIG RNS RPM TDBHL TR2 UKHRP VDV NPM PMFND 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c517t-f9fc12313db61e7d59eeaca465d01adc0c4e3a54d426e3aff274ea3095ed44713 |
IEDL.DBID | M48 |
ISSN | 1179-1322 |
IngestDate | Wed Aug 27 01:20:35 EDT 2025 Thu Aug 21 18:13:49 EDT 2025 Thu Jul 10 18:00:38 EDT 2025 Tue Jun 17 20:27:49 EDT 2025 Tue Jun 10 20:27:04 EDT 2025 Thu Jan 02 23:01:11 EST 2025 Tue Jul 01 03:18:23 EDT 2025 Thu Apr 24 23:12:10 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | esophageal squamous cell carcinoma fibrinogen prognostic indicator lymphocyte |
Language | English |
License | http://creativecommons.org/licenses/by-nc/3.0 This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c517t-f9fc12313db61e7d59eeaca465d01adc0c4e3a54d426e3aff274ea3095ed44713 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work |
ORCID | 0000-0001-7834-5103 0000-0002-0065-7542 0000-0003-3760-5575 0000-0002-1622-6747 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/CMAR.S204938 |
PMID | 31213896 |
PQID | 2243484794 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_7eb121f007054d9fbce6d2eeaaf2bb4e pubmedcentral_primary_oai_pubmedcentral_nih_gov_6536709 proquest_miscellaneous_2243484794 gale_infotracmisc_A610584767 gale_infotracacademiconefile_A610584767 pubmed_primary_31213896 crossref_citationtrail_10_2147_CMAR_S204938 crossref_primary_10_2147_CMAR_S204938 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20190501 |
PublicationDateYYYYMMDD | 2019-05-01 |
PublicationDate_xml | – month: 05 year: 2019 text: 20190501 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand |
PublicationTitle | Cancer management and research |
PublicationTitleAlternate | Cancer Manag Res |
PublicationYear | 2019 |
Publisher | Dove Medical Press Limited Dove Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Dove – name: Dove Medical Press |
SSID | ssj0069134 |
Score | 2.1992154 |
Snippet | The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic... Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the... Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the... Ningbo Fan,1,* Dongni Chen,1,* Jiabo Zheng,2 Zhesheng Wen,1 Peng Lin11Department of Thoracic Oncology, State Key Laboratory of Oncology in South China,... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 4719 |
SubjectTerms | Analysis Carcinoma China Development and progression Elderly patients Esophageal cancer esophageal squamous cell carcinoma Fibrin Fibrinogen Health aspects lymphocyte Lymphocytes Medical research Morbidity Mortality Original Research Prognosis prognostic indicator Squamous cell carcinoma Surgery Tumors |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nj9MwELXQHhAXxDeBBRkJxAGZrRPni1tZsVohlQOw0t4sxx4LpK5d2ixSfxN_kpk4rRohxIVbW7utk3mZebbHbxh72eUNIE32Arm8o6UbEEYpI1QnS1c6knyidcjFp-r8Qn28LC8PSn1RTliSB0437qRGZ5JLT7I0pXKt7yxULgcwxuddp4C8L8a83WQq-eBqt5-McBM030op71ST5-R0Mf_89kuOzJjOpBwEo0Gz_0_PfBCapmmTB3Ho7A67PRJIPk8Dv8tuQLjHbi7GLfL77Nech_gTlny1hriCJOzNV0iSrwynDWpL02zeR-qA73pOKVohbmDDkcDyUWh1w2mFlgNVOUCXg_-4-XFtaJ2A01o_t1SDKET8zaHKOF-bYcNn_wXbx6vtO-7pREGIiFLRR7HcInai3fbAB-A9YBdnH76enouxIoOwpax74VtvMdTJwnWVhNqVLRrCGlWVbiaNszOroDBoJ4z7-MJ7nPOCKZDGgVMYBouH7CjEAI8Z9-go2qpBD4PYsE42jSR2IjuXu1ljZhl7szONtqNcOVXNWGqctpAhNRlSj4bM2Kt971WS6fhLv_dk5X0fEtcePkDI6RFy-l-Qy9hrwogmF4BDsmY8yYAXRmJaeo6UlHafqzpjx5Oe-OjaSfOLHco0NVG-WwC0pEZiVaiG1P8z9iihbj_mglT4mrbKWD3B4-Sipi3h-7dBObwqB72-J__jLjxlt5A8tin585gd9etreIYEre-eD8_ibzj4Pk4 priority: 102 providerName: Directory of Open Access Journals |
Title | A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31213896 https://www.proquest.com/docview/2243484794 https://pubmed.ncbi.nlm.nih.gov/PMC6536709 https://doaj.org/article/7eb121f007054d9fbce6d2eeaaf2bb4e |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3battAEB1ygZCX0HuVpmYLLX0oSr3S6lYoxQlJQ8GhpDX4Taz20hYcyZGUUn9Tf7Izkiws0rwY21rJWs_ZnbM7ozMArzMvNkiTrYtcXtPWjXGlENIVGQ90oEnyifYhp5fhxUx8mQfzLVhXG-3-wOq_SzuqJzUrF8d_blafcMB_pDRmLqL3p9PJ1fE3D7muH2_DLvqkiGoZTEUfTwjX8WWEn0vrrzYF_s7Z-7Dnk8ZZTBr-G36qkfO_O2lveK1hRuWGizp_AAcdt2STFgwPYcvkj2Bv2kXPH8PfCcuL32bBlqXBXraa32yJ_PlaMopdK1qBs7qgBvipZpS9lReVqRhyW9ZpsFaMNm-ZoQIIOBvhL1Y3t5K2EBiFAZii8kR5gddsCpCzUjaxoP4EVRfXqw_M0sMGeYEAduvCXawQVoVa1YY1mHwCs_Oz76cXbleswVUBj2rXJlahF-S-zkJuIh0kBud0KcJAj7nUaqyE8WUgNFICfGMtLoeN9JHhGS3QQ_pPYScvcvMcmMU5JAljnHwQNkrzOOZEXHimPT2O5diBd2vTpKpTMqeCGosUVzRk05RsmnY2deBN33rZKnjc0-6ErNy3Id3t5oui_JF2wziN0LV53JJIEnYlsZkyofawp9J6WSaMA28JIynhFW9Jye4hB-wY6WylE2SrFJgOIweOBi1xVKvB4VdrlKV0iFLhcoOWTJFz-SKmwgAOPGtR19_zGrwORAM8Djo1PJL_-tmIiodBI-V3eO81X8A-ksWkTfY8gp26vDUvkZDV2Qi2o3k0gt2Ts8uvV6NmWwNfP8_5qBmF_wD9iDps |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+novel+preoperative+plasma+indicator+to+predict+prognoses+for+patients+with+esophageal+squamous+cell+carcinoma+after+radical+esophagectomy%3A+fibrinogen-to-lymphocyte+ratio&rft.jtitle=Cancer+management+and+research&rft.au=Fan%2C+Ningbo&rft.au=Chen%2C+Dongni&rft.au=Zheng%2C+Jiabo&rft.au=Wen%2C+Zhesheng&rft.date=2019-05-01&rft.issn=1179-1322&rft.eissn=1179-1322&rft.volume=11&rft.spage=4719&rft_id=info:doi/10.2147%2FCMAR.S204938&rft_id=info%3Apmid%2F31213896&rft.externalDocID=31213896 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1179-1322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1179-1322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1179-1322&client=summon |